Avanir Publishes Phase III Data For Neuropathic Pain Combo
By Catherine Shaffer
Thursday, February 9, 2012
To create product candidate AVP-923, Avanir Pharmaceuticals Inc. bundled cough medicine dextromethorphan with antiarrhythmic agent quinidine. Now the duo of medicine cabinet staples has prevailed against an unrelated third indication: diabetic peripheral neuropathy.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.